Australian shares: A once-in-a-decade chance to build wealth?

At first glance, the Australian share market doesn’t look particularly cheap.

Even after the recent pullback driven by escalating tensions in the Middle East, the S&P/ASX 200 Index (ASX: XJO) is still sitting not far from record highs. Many investors are also sitting on very healthy gains thanks to the strong performance of bank and mining shares over the past year.

But when I look beneath the surface of the market, I see something quite different.

In my view, a large part of the market has already experienced its own bear market. And that disconnect could be creating a rare opportunity for long-term investors.

The strength in banks and miners is masking the real picture

The ASX 200 is heavily concentrated in just a handful of sectors.

Banks and mining companies make up a very large portion of the index, and both groups have performed strongly. Iron ore, oil, copper, and gold producers have benefited from resilient commodity prices, while the major banks have rallied significantly as investors chased reliable dividends.

Because of their large weightings, that strength has helped keep the overall market relatively elevated.

But outside those sectors, the story has been very different.

Many high-quality Australian shares across healthcare, technology, consumer, and industrial sectors have fallen sharply over the past year.

Plenty of quality Australian shares are already down heavily

Some well-known businesses have been pushed down to 52-week lows or worse during the recent sell-off.

Companies such as CSL Ltd (ASX: CSL), Sigma Healthcare Ltd (ASX: SIG), Amcor plc (ASX: AMC), Treasury Wine Estates Ltd (ASX: TWE), and Flight Centre Travel Group Ltd (ASX: FLT) all saw their share prices fall to 52-week lows last week as investors reacted to market volatility and shifting sentiment.

At the same time, a number of well-known Australian shares are now trading more than 30% below their highs from the past year.

Businesses like Telix Pharmaceuticals Ltd (ASX: TLX), Xero Ltd (ASX: XRO), WiseTech Global Ltd (ASX: WTC), Pro Medicus Ltd (ASX: PME), James Hardie Industries plc (ASX: JHX), Cochlear Ltd (ASX: COH), Temple & Webster Group Ltd (ASX: TPW), and Aristocrat Leisure Ltd (ASX: ALL) have all experienced substantial declines despite still operating in industries with strong long-term growth prospects.

Personally, I think it’s important to recognise that many of these businesses haven’t suddenly become bad companies. In many cases, the share price weakness reflects changing sentiment, macroeconomic concerns, or broader market rotations rather than a collapse in the underlying businesses.

Market pullbacks can create powerful opportunities

History shows that periods of widespread pessimism can sometimes create the best opportunities for long-term investors.

When high-quality Australian shares fall sharply alongside the broader market, investors occasionally get the chance to buy great businesses at prices that simply weren’t available during more optimistic times.

Of course, not every falling stock is a bargain. Some companies decline for very good reasons, and careful analysis is always important.

But when large numbers of quality businesses are trading well below their previous highs at the same time, it can create an environment that favours patient investors.

A long-term perspective matters

One thing I always remind myself is that wealth in the share market is usually built over many years.

Trying to perfectly time the bottom is almost impossible. Instead, long-term investors often benefit from gradually building positions in strong businesses when sentiment is weak.

If the current pullback deepens, that opportunity could become even more attractive.

Foolish Takeaway

The ASX 200 might still look relatively strong on the surface, but the broader market tells a very different story.

Many high-quality Australian shares are already down 30% to 50% from their highs or sitting at multi-year lows. In my view, the strength in bank and mining shares has largely masked how difficult the past year has been for many other sectors.

That disconnect could mean something important. For long-term investors willing to look beyond the headline index level, this period may turn out to be one of the most attractive opportunities in years to start building wealth in Australian shares.

The post Australian shares: A once-in-a-decade chance to build wealth? appeared first on The Motley Fool Australia.

More reading

• This ASX small cap could be in a sweet spot for construction demand
• Two ASX shares on the rebound
• ASX ETFs that target undervalued sectors
• ASX travel shares are hovering near yearly lows – time to buy?
• New Hope Corporation 1H FY26: Profit falls, interim dividend declared

Motley Fool contributor Grace Alvino has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, Telix Pharmaceuticals, Temple & Webster Group, Treasury Wine Estates, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Amcor Plc, Treasury Wine Estates, WiseTech Global, and Xero. The Motley Fool Australia has recommended CSL, Cochlear, Flight Centre Travel Group, Pro Medicus, Telix Pharmaceuticals, and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.